Variable G protein determinants of GPCR coupling selectivity
暂无分享,去创建一个
[1] David E. Gloriam,et al. Receptor selectivity between the G proteins Gα12 and Gα13 is defined by a single leucine-to-isoleucine variation , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[2] T. Flock,et al. Crystal structure of rhodopsin in complex with a mini-Go sheds light on the principles of G protein selectivity , 2018, Science Advances.
[3] Naomi R. Latorraca,et al. Structure of the mu-opioid receptor-Giprotein complex. , 2018 .
[4] Arthur Christopoulos,et al. Structure of the adenosine-bound human adenosine A1 receptor–Gi complex , 2018, Nature.
[5] O. Kuybeda,et al. Cryo-EM structure of human rhodopsin bound to an inhibitory G protein , 2018, Nature.
[6] J. García-Nafría,et al. Cryo-EM structure of the serotonin 5-HT1B receptor coupled to heterotrimeric Go , 2018, Nature.
[7] Naomi R. Latorraca,et al. Structure of the μ Opioid Receptor-Gi Protein Complex , 2018, Nature.
[8] Naomi R. Latorraca,et al. Gi- and Gs-coupled GPCRs show different modes of G-protein binding , 2018, Proceedings of the National Academy of Sciences.
[9] Alexander S. Hauser,et al. GPCRdb in 2018: adding GPCR structure models and ligands , 2017, Nucleic Acids Res..
[10] J. Wess,et al. Lack of beta-arrestin signaling in the absence of active G proteins , 2018, Nature Communications.
[11] Arthur Christopoulos,et al. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein‐coupled receptors , 2017, British journal of pharmacology.
[12] M. Madan Babu,et al. Selectivity determinants of GPCR–G-protein binding , 2017, Nature.
[13] J. Aoki,et al. Purinergic Receptor Transactivation by the β2-Adrenergic Receptor Increases Intracellular Ca2+ in Nonexcitable Cells , 2017, Molecular Pharmacology.
[14] G. Milligan,et al. The emerging pharmacology and function of GPR35 in the nervous system , 2017, Neuropharmacology.
[15] Donna Webb,et al. Coupling optogenetic stimulation with NanoLuc-based luminescence (BRET) Ca++ sensing , 2016, Nature Communications.
[16] C. Tate,et al. Engineering a minimal G protein to facilitate crystallisation of G protein-coupled receptors in their active conformation , 2016, Protein engineering, design & selection : PEDS.
[17] N. Vaidehi,et al. Structural Elements in the Gαs and Gαq C Termini That Mediate Selective G Protein-coupled Receptor (GPCR) Signaling* , 2016, The Journal of Biological Chemistry.
[18] A. J. Venkatakrishnan,et al. Universal allosteric mechanism for Gα activation by GPCRs , 2015, Nature.
[19] H. Horiuchi. Seven-transmembrane receptors , 2015 .
[20] Helmut Grubmüller,et al. Position of transmembrane helix 6 determines receptor G protein coupling specificity. , 2014, Journal of the American Chemical Society.
[21] T. Lan,et al. Sensitive and High Resolution Localization and Tracking of Membrane Proteins in Live Cells with BRET , 2012, Traffic.
[22] S. Rasmussen,et al. Crystal Structure of the β2Adrenergic Receptor-Gs protein complex , 2011, Nature.
[23] Xavier Deupi,et al. The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex , 2009, Proceedings of the National Academy of Sciences.
[24] N. Lambert,et al. The c-terminus of GRK3 indicates rapid dissociation of G protein heterotrimers. , 2009, Cellular signalling.
[25] Michel Bouvier,et al. Real-time monitoring of receptor and G-protein interactions in living cells , 2005, Nature Methods.
[26] R. Lefkowitz,et al. Signalling: Seven-transmembrane receptors , 2002, Nature Reviews Molecular Cell Biology.
[27] B. Kobilka,et al. Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[28] J. Bockaert,et al. A Novel Site on the Gα-protein That Recognizes Heptahelical Receptors* , 2001, The Journal of Biological Chemistry.
[29] J. Bockaert,et al. A novel site on the Galpha -protein that recognizes heptahelical receptors. , 2001, The Journal of biological chemistry.
[30] C. Berlot,et al. A surface-exposed region of G(salpha) in which substitutions decrease receptor-mediated activation and increase receptor affinity. , 2000, Molecular pharmacology.
[31] J. Wess,et al. Molecular basis of receptor/G-protein-coupling selectivity. , 1998, Pharmacology & therapeutics.
[32] M. Grossmann,et al. G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.
[33] J. Wess,et al. The N-terminal Extension of Gαq Is Critical for Constraining the Selectivity of Receptor Coupling* , 1997, The Journal of Biological Chemistry.
[34] J. Wess,et al. Molecular basis of receptor/G protein coupling selectivity studied by coexpression of wild type and mutant m2 muscarinic receptors with mutant G alpha(q) subunits. , 1997, Biochemistry.
[35] B. Conklin,et al. Carboxyl-terminal mutations of Gq alpha and Gs alpha that alter the fidelity of receptor activation. , 1996, Molecular pharmacology.
[36] J. Shine,et al. Protein-coupled Receptors , 1996 .
[37] J. Wess,et al. Identification of a receptor/G-protein contact site critical for signaling specificity and G-protein activation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[38] M. Simon,et al. Multiple regions of G alpha 16 contribute to the specificity of activation by the C5a receptor. , 1995, Molecular pharmacology.
[39] E. Lakatta,et al. Functional coupling of the beta 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. , 1995, Molecular pharmacology.
[40] B. Conklin,et al. Substitution of three amino acids switches receptor specificity of Gqα to that of Giα , 1993, Nature.
[41] R. Seifert,et al. Histamine increases cytosolic Ca2+ in dibutyryl-cAMP-differentiated HL-60 cells via H1 receptors and is an incomplete secretagogue. , 1992, Molecular pharmacology.
[42] Melvin I. Simon,et al. Diversity of G proteins in signal transduction , 1991, Science.
[43] W. Simonds,et al. Gi2 mediates alpha 2-adrenergic inhibition of adenylyl cyclase in platelet membranes: in situ identification with G alpha C-terminal antibodies. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[44] H. Hamm,et al. Site of G protein binding to rhodopsin mapped with synthetic peptides from the alpha subunit. , 1988, Science.
[45] W. Heideman,et al. Identification of receptor contact site involved in receptor–G protein coupling , 1987, Nature.
[46] J. Moss,et al. Pertussis toxin-catalyzed ADP-ribosylation of transducin. Cysteine 347 is the ADP-ribose acceptor site. , 1985, The Journal of biological chemistry.
[47] R. Lefkowitz,et al. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. , 1980, The Journal of biological chemistry.
[48] M. Maguire,et al. An agonist-specific effect of guanine nucleotides on binding to the beta adrenergic receptor. , 1976, Molecular pharmacology.